Steve Gullans Q&A at TEDMED 2013
Scientist, entrepreneur, and investor Steve Gullans talks with Pritpal S Tamber about his unique perspective of the future of pharmaceuticals.
Latest Posts
When is “safe dosing” a dangerous prescription?
Scientist, entrepreneur, and investor Steve Gullans shares his unique vantage point into the future of drug discovery and dosing at TEDMED 2013.
Can patient data have a second life?
Why should science be limited to studying cohorts? Amy P. Abernethy, MD, a medical oncologist and palliative medicine physician,wants to gather donated health data at its source: A …
What are the secrets of breathing? (Part 1)
Breath is life, a fact we take for granted all too often, as Charity Tillemann-Dick discovered. The soprano tells of re-learning to breathe, one gasp at a time.
What are the secrets of breathing? (Part 2)
Breath is life, a fact we take for granted all too often, as Charity Tillemann-Dick discovered. The soprano tells of re-learning to breathe, one gasp at a time.
Elazar Edelman: Q&A at TEDMED 2013
Elazer Edelman answers questions about how a “big bang” of scientific knowledge can drive potential collaborators apart.
Elazer Edelman at TEDMED 2013
Does having an MD or PhD lead to medical innovation? Doctor and biomedical entrepreneur Elazer Edelman shares the hidden risks in assuming more knowledge is better knowledge.
Why couldn’t we just have given her intravenous oxygen?
John Kheir is a staff physician in the Cardiac Intensive Care Unit at Boston Children’s Hospital and an Instructor of Pediatrics at Harvard Medical School. He has developed …
Ending Pandemics: How close are we today?
Larry Brilliant, President and CEO of the Skoll Global Threats Fund describes how global public-private partnerships are helping to save humanity from disaster.
When is a wheelchair an ultra-light submarine?
Sue Austin, a multimedia, performance and installation artist, talks about her groundbreaking series of live-art and video works of an underwater wheelchair flying along mid water.